Notice Number: NOT-OD-19-100

Key Dates

Issued by
National Institutes of Health (NIH)

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

National Cancer Institute (NCI)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

Purpose

To inform the research community that The National Institutes of Health (NIH) Tobacco Regulatory Science Program (TRSP), participating NIH Institutes and Centers (ICs) and the United States Food and Drug Administration (FDA) Center for Tobacco Products (CTP) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit R21 applications for research stimulating exploratory research relevant to the mission of the Food and Drug Administration (FDA) - Center for Tobacco Products (CTP) using existing (publicly available) biospecimen currently stored in repositories in the United States. This will include, but not be limited to, collections associated with the Population Assessment of Tobacco and Health (PATH) Study, the National Health and Nutrition Examination Survey (NHANES), the National Heart, Lung and Blood Institute’s (NHLBI) Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC), and the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Proposed research should seek to maximize the scientific value of these stored collections and to provide researchers with an opportunity to generate preliminary data for subsequent research proposals. While other publicly available datasets would be considered, depending on analyses to be conducted, nationally representative analyses will receive priority. These applications need to provide justification why the data set is unique and the research questions cannot be answered from a publicly available, nationally representative, data set.

Research Initiative Details

TBD

Funding Information

Estimated Total Funding NIH, via support from the FDA Center for Tobacco products (CTP), intends to fund up to 7 R21s for fiscal year 2020. Future year funding will depend on availability of funds
Expected Number of Awards 7
Estimated Award Ceiling The combined budget for direct cost for the entire project period may not exceed $275,000. No more than $200,000 in direct costs may be requested in a single year.
Primary CFDA Numbers 93.077

Anticipated Eligible Organizations

Inquiries

Please direct all inquiries to: